Michael Stansky Insider Profile
11 Followers
Michael Stansky, Director at TriSalus Life Sciences, holds 1.64M shares in TriSalus Life Sciences (Ticker: TLSI), holds 0.00 shares in Mako Surgical (Ticker: MAKO). Most recently, Michael Stansky Bought ― shares of TriSalus Life Sciences on May 18, 2026 for an estimated value of $1.52M.
Michael Stansky TriSalus Life Sciences (TLSI)Director
TriSalus Life Sciences (TLSI)
Director
Ranked #42,495 out of 109,030 Corporate Insiders
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+23.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Michael Stansky's holdings
Insider Roles
Director
Roles that Michael Stansky holds in companies
Most Profitable Insider Trade
The most profitable trade made by Michael Stansky
Michael Stansky's Trading History
TriSalus Life Sciences
May 18, 2026
Director
Informative Buy
1.52M
$7.65M
Mako Surgical
―
―
―
―
List of latest transactions for each holding click on a transaction to see Michael Stansky's performance on stock
You May Also Like
Michael Stansky insider profile FAQ
What is the percentage of profitable transactions made by Michael Stansky?
The percentage of profitable transactions made by Michael Stansky is 50%.
What is the average return per transaction made by Michael Stansky?
The average return per transaction made by Michael Stansky is 23.70%.
What stocks does Michael Stansky hold?
Michael Stansky holds: TLSI, MAKO stocks.
What was Michael Stansky’s latest transaction?
Michael Stansky latest transaction was an Informative Buy of $1.52M.
What was Michael Stansky's most profitable transaction?
Michael Stansky’s most profitable transaction was an Informative Buy of TLSI stock on May 18, 2026. The return on the trade was 53.90%.
What is Michael Stansky's role in TriSalus Life Sciences?
Michael Stansky's role in TriSalus Life Sciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.